Inspire Medical Systems (INSP) has a profit margin of 15.03%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for INSP is 15.03% as of June 2026. That compares with 6.17% in the prior-year period — up 143.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Inspire Medical Systems's historical trend and sector peers before judging valuation or financial health.
Over the past year, INSP's profit margin moved from 6.17% to 15.03% — a 143.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Inspire Medical Systems's valuation or profitability profile.
Against Healthcare companies, INSP currently prints 15.03% for profit margin, while the sector average sits near 21.34%. That is roughly 29.6% below the sector mean. Large gaps often invite a closer look at Inspire Medical Systems's growth, margins, and balance sheet.
Profit Margin shows how effectively Inspire Medical Systems converts resources into returns. At 15.03%, INSP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.17% in the prior-year period — up 143.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting INSP's profit margin (15.03%), review year-over-year change from 6.17%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.